Positioning of non-factor replacement therapy in the hemophilia treatment
Michio Sakai
openalex +2 more sources
Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A [PDF]
Johnny Mahlangu +26 more
openalex +1 more source
Joint tissue plasticity in hemophilia: insights from the Joint Activity and Damage Exam ultrasound protocol. [PDF]
Sheth P +14 more
europepmc +1 more source
Identifying hemophilia B carriers: Utility of aPTT, factor IX levels and ratios of factor IX to other Vitamin K dependent factors [PDF]
Michael Shu +6 more
openalex +1 more source
Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B.
Wolfgang A. Miesbach +13 more
semanticscholar +1 more source
A report of clinicians’ attitude survey of acquired hemophilia A in daily clinical practice
Yoshinobu Seki +4 more
openalex +2 more sources
Inhibitors in German Hemophilia A Patients Treated with a Double Virus Inactivated Factor VIII Concentrate Bind to the C2 Domain of FVIII Light Chain [PDF]
R Laub +7 more
openalex +1 more source
Clinical internship at UC San Diego Hemophilia and Thrombosis Treatment Center
Azusa Nagao
openalex +2 more sources
Emicizumab in infants: not just cost-effective but mandatory. [PDF]
Young G.
europepmc +1 more source
An intragenic deletion of the factor IX gene in a family with hemophilia B. [PDF]
S.-H. Chen +6 more
openalex +1 more source

